Our objective was to evaluate effects of levothyroxine ( l-T4 ) supplementation against neurodevelopmental outcomes at 18 months of corrected age in very-low-birth-weight ( VLBW ) infants with hypothyroxinemia but without elevated thyroid-stimulating hormone ( TSH ) concentration .